Login / Signup

Analysis of prognostic factors in diffuse large B-cell lymphoma associated with rheumatic diseases.

Vadim Romanovich GorodetskiyNatalya ProbatovaTatiana ObukhovaVladimir Vasilyev
Published in: Lupus science & medicine (2022)
Except for the more common non-GCB subtype, we did not identify any other prognostic factor that could influence the prognosis of patients with RD-associated DLBCL. We believe that short OS in our patients was predominantly associated with decreased tolerance to lymphoma treatment.
Keyphrases
  • prognostic factors
  • diffuse large b cell lymphoma
  • epstein barr virus
  • end stage renal disease
  • chronic kidney disease
  • african american
  • replacement therapy